Archive for July, 2019

  • Isofol Announces Recent Advisory Board Meeting Covering Development Plan for arfolitixorin

    Isofol Announces Recent Advisory Board Meeting Covering Development Plan for arfolitixorin GOTHENBURG, Sweden, July 15, 2019 – Isofol Medical AB…

    by
  • Isofol Announces Recent Advisory Board Meeting Covering Development Plan for arfolitixorin

    GOTHENBURG, Sweden, July 15, 2019 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced the outcome of…

    by
  • Isofol Receives Clinical Use Patent Approval in the United States for Drug Candidate arfolitixorin

    GOTHENBURG, Sweden, June 25, 2019 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced approval of a…

    by